Restless legs syndrome and risk of incident cardiovascular disease in women and men: Prospective cohort study

BMJ Open

Volumn 2, Issue 2, 2012, Pages

  Winter, Anke C ^a   Schürks, Markus ^a,b   Glynn, Robert J ^a   Buring, Julie E ^a   Gaziano, J Michael ^a   Berger, Klaus ^c   Kurth, Tobias ^a,d,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d INSERM   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; BETA CAROTENE; PLACEBO;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEATH; DISEASE ASSOCIATION; FEMALE; HEALTH PRACTITIONER; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PATHOPHYSIOLOGY; PHYSICIAN; RESTLESS LEGS SYNDROME; SENSITIVITY ANALYSIS; STROKE; WOMEN'S HEALTH;

EID: 84860160051     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-000866     Document Type: Article

References (30)

1. Berger K, Kurth T. RLS epidemiologydfrequencies, risk factors and methods in population studies. Mov Disord 2007;22(Suppl 18):S420-3.
2. Innes KE, Selfe TK, Agarwal P. Prevalence of restless legs syndrome in North American and Western European populations: a systematic review. Sleep Med 2011;12:623-34.
3. Paulus W, Dowling P, Rijsman R, et al. Pathophysiological concepts of restless legs syndrome. Mov Disord 2007;22:1451-6. (Pubitemid 47280631)
4. Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007;39:1000-6. (Pubitemid 47185185)
5. Winkelmann J, Czamara D, Schormair B, et al. Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet 2011, 7: e1002171.
6. Chen NH, Chuang LP, Yang CT, et al. The prevalence of restless legs syndrome in Taiwanese adults. Psychiatry Clin Neurosci 2010;64:170-8.
7. Juuti AK, Laara E, Rajala U, et al. Prevalence and associated factors of restless legs in a 57-year-old urban population in northern Finland. Acta Neurol Scand 2009;122:63-9.
8. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002;53:547-54.
9. Ulfberg J, Nystrom B, Carter N, et al. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001;16:1159-63. (Pubitemid 36041234)
10. Wesstrom J, Nilsson S, Sundstrom-Poromaa I, et al. Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause. Climacteric 2008;11:422-8.
11. Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006;7:545-52. (Pubitemid 44480745)
12. Winkelman JW, Shahar E, Sharief I, et al. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008;70:35-42.
13. Elwood P, Hack M, Pickering J, et al. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health 2006;60:69-73. (Pubitemid 43028633)
14. Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep 2009;32:589-97.
15. Guggisberg AG, Hess CW, Mathis J. The significance of the sympathetic nervous system in the pathophysiology of periodic leg movements in sleep. Sleep 2007;30:755-66. (Pubitemid 46854763)
16. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989;321:129-35.
17. Christen WG, Gaziano JM, Hennekens CH. Design of Physicians' Health Study IIda randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol 2000;10:125-34. (Pubitemid 30089022)
18. Rexrode KM, Lee IM, Cook NR, et al. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 2000;9:19-27. (Pubitemid 30148098)
19. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304.
20. Berger K, Luedemann J, Trenkwalder C, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004;164:196-202. (Pubitemid 38140407)
21. Hogl B, Kiechl S, Willeit J, et al. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology 2005;64:1920-4. (Pubitemid 40800707)
22. Rothdach AJ, Trenkwalder C, Haberstock J, et al. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000;54:1064-8. (Pubitemid 30151846)
23. Berger K, von Eckardstein A, Trenkwalder C, et al. Iron metabolism and the risk of restless legs syndrome in an elderly general populationdthe MEMO-Study. J Neurol 2002;249:1195-9. (Pubitemid 35025093)
24. Atiya M, Kurth T, Berger K, et al. Interobserver agreement in the classification of stroke in the Women's Health Study. Stroke 2003;34:565-7. (Pubitemid 36206365)
25. Berger K, Kase CS, Buring JE. Interobserver agreement in the classification of stroke in the physicians' health study. Stroke 1996;27:238-42.
26. Benediktsdottir B, Janson C, Lindberg E, et al. Prevalence of restless legs syndrome among adults in Iceland and Sweden: lung function, comorbidity, ferritin, biomarkers and quality of life. Sleep Med 2010;11:1043-8.
27. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-19. (Pubitemid 36527231)
28. Koo BB, Blackwell T, Ancoli-Israel S, et al. Association of incident cardiovascular disease with periodic limb movements during sleep in older men: Outcomes of Sleep Disorders in Older Men (MrOS) Study. Circulation 2011;124:1223-31.
29. La Manna G, Pizza F, Persici E, et al. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. Nephrol Dial Transpl 2011;26:1976-83.
30. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123:894-900. (Pubitemid 16049247)